Abstract
PURPOSE: Chronic obstructive pulmonary disease (COPD) is a smoking related inflammatory lung disease. Tumor necrosis factor-alpha is thought to play an important role in the induction and maintenance of this inflammation. No effective anti-inflammatory agents are currently available to reduce airway inflammation in COPD. Aim: To evaluate the anti-inflammatory effect of the anti-TNF drug infliximab in patients with mild COPD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
